Larvol Delta - CNS-Pharmaceuticals-Announces-Activation-of-First-Clinical-Trial-Sites-in-Europe-for-Ongoing-Potentially-Pivotal-Global-Trial-Evaluating-Berubicin-for-the-Treatment-of-GBM-

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-activation-of-first-clinical-trial-sites-in-europe-for-ongoing-potentially-pivotal-global-trial-evaluating-berubicin-for-the-treatment-of-gbm-301634910.html

Sep 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next